These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8190010)

  • 1. Bupivacaine kinetic changes induced by diltiazem in mice.
    Bruguerolle B; Lorec AM
    Life Sci; 1994; 54(19):PL315-9. PubMed ID: 8190010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of bupivacaine after clonidine pretreatment in mice.
    Bruguerolle B; Attolini L; Lorec AM; Gantenbein M
    Can J Anaesth; 1995 May; 42(5 Pt 1):434-7. PubMed ID: 7614654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of bupivacaine after levcromakalim treatment in mice.
    Gantenbein M; Attolini L; Bruguerolle B
    J Pharm Pharmacol; 1997 Mar; 49(3):293-5. PubMed ID: 9231348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupivacaine kinetics during hyperthermia in rats.
    Bruguerolle B; Roucoules X; Attolini L; Lorec AM
    Can J Anaesth; 1994 Mar; 41(3):253-6. PubMed ID: 8187262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of bupivacaine after nicorandil treatment in mice.
    Gantenbein M; Attolini L; Bruguerolle B
    J Pharm Pharmacol; 1996 Jul; 48(7):749-52. PubMed ID: 8866342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette smoke increases bupivacaine metabolism in rats.
    Bruguerolle B; Attolini L; Roucoules X; Lorec AM
    Can J Anaesth; 1994 Aug; 41(8):733-7. PubMed ID: 7923523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine effects on bupivacaine local anaesthetic activity and pharmacokinetics of bupivacaine in mice.
    Gantenbein M; Abat C; Attolini L; Pisano P; Emperaire N; Bruguerolle B
    Life Sci; 1997; 61(20):2027-33. PubMed ID: 9366510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcium antagonists on binding of local anesthetics to plasma proteins and erythrocytes in mice.
    Jacob D; Grignon S; Attolini L; Gantenbein M; Bruguerolle B
    Pharmacology; 1996 Oct; 53(4):219-23. PubMed ID: 8958560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute toxicity of bupivacaine metabolites in mice.
    Bruguerolle B; Attolini L; Gantenbein M
    Clin Exp Pharmacol Physiol; 1994 Dec; 21(12):997-9. PubMed ID: 7736659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of bupivacaine kinetic changes induced by flumazenil in mice.
    Bruguerolle B; Lorec AM
    Life Sci; 1993; 52(17):PL165-7. PubMed ID: 8464340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tobacco smoke exposure on the kinetics of bupivacaine in mice.
    Attolini L; Gantenbein M; Bruguerolle B
    Life Sci; 1997; 60(10):725-34. PubMed ID: 9064477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of bupivacaine toxicity by diltiazem in anaesthetized dogs.
    Finegan BA; Whiting RW; Tam YK; Clanachan AS
    Br J Anaesth; 1992 Nov; 69(5):492-7. PubMed ID: 1467082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupivacaine kinetics in serum, cardiac and brain tissues: effect of diazepam pretreatment in mice.
    Bruguerolle B; Merland V; Prat M
    Life Sci; 1991; 48(6):569-74. PubMed ID: 1992291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal variations in the kinetics of bupivacaine in the mouse.
    Attolini L; Gantenbein M; Lorec AM; Bruguerolle B
    Eur J Drug Metab Pharmacokinet; 1996; 21(3):257-60. PubMed ID: 8980925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A.
    Gantenbein M; Attolini L; Bruguerolle B; Villard PH; Puyoou F; Durand A; Lacarelle B; Hardwigsen J; Le-Treut YP
    Drug Metab Dispos; 2000 Apr; 28(4):383-5. PubMed ID: 10725304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic analysis of ropivacaine and its metabolite 2',6'-pipecoloxylidide from pooled data in neonates, infants, and children.
    Aarons L; Sadler B; Pitsiu M; Sjövall J; Henriksson J; Molnár V
    Br J Anaesth; 2011 Sep; 107(3):409-24. PubMed ID: 21693469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional transport and metabolism of ropivacaine and its CYP3A4 metabolite PPX in human intestine.
    Berggren S; Lennernäs P; Ekelund M; Weström B; Hoogstraate J; Lennernäs H
    J Pharm Pharmacol; 2003 Jul; 55(7):963-72. PubMed ID: 12906753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of bupivacaine after short and prolonged infusions in conscious dogs.
    Mazoit JX; Lambert C; Berdeaux A; Gerard JL; Froideveaux R
    Anesth Analg; 1988 Oct; 67(10):961-6. PubMed ID: 3421499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal changes in bupivacaine kinetics.
    Bruguerolle B; Prat M
    J Pharm Pharmacol; 1987 Feb; 39(2):148-9. PubMed ID: 2882005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of a selected ion monitoring technique to study the disposition of bupivacaine in mother, fetus, and neonate following epidural anesthesia for cesarean section.
    Kuhnert PM; Kuhnert BR; Stitts JM; Gross TL
    Anesthesiology; 1981 Dec; 55(6):611-7. PubMed ID: 7305051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.